Advertisement

The mode of action of IUDs

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      In women, IUDs produce alterations of the uterine environment in terms of a pronounced foreign body reaction. This biological response may interfere with steps of the reproductive process that normally take place before the ovum reaches the uterine cavity. In order to discuss this hypothesis on the mechanism of action of IUDs, this review is focussed on 1) detection in urine and blood of substances alleged to be specifically produced by the embryo, 2) migration of gametes in the female genital tract, and 3) microscopic features of ova recovered from the genital tract.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Corfman P.A.
        • Segal S.J.
        Biologic effects of intrauterine devices.
        Am J. Obst Gyn. 1968; 100: 448-459
        • Sagiroglu N.
        • Sagiroglu E.
        Biologic mode of action of Lippes loop in intrauterine contraception.
        Am J. Obst Gyn. 1970; 106: 506-515
        • Gupta P.K.
        • et al.
        Cellular response in the uterine cavity after IUD insertion and structural changes of the IUD.
        Contraception. 1971; 4: 375-384
        • Myatt L.
        • et al.
        Macrophages on intrauterine contraceptive devices produce prostaglandins.
        Nature. 1975; 257: 227-228
        • Foley M.E.
        • et al.
        Production of fibrinolytic enzymes by macrophages on intrauterine contraceptive devices.
        Br J. Obst Gyn. 1978; 85: 551-556
        • Trebichansky I.
        • Nylicek O.
        Description of the population and ultra-structure of cells on IUDs.
        Acta Cytologica. 1979; 23: 366-369
        • Casslén B.
        • et al.
        The cellular composition of uterine fluid in IUD users — A quantitative study.
        Contraception. 1981; 24: 685-693
        • O'Rahilly R.
        Developmental Stages in Human Embryos.
        Carnegie Institute, Washington1973 (Part A)
        • Morton H.
        • et al.
        An early pregnancy factor detected in human serum by the rosette inhibition test.
        Lancet. 1977; i: 394-397
        • Rolfe B.E.
        Detection of fetal wastage.
        Fertil Steril. 1982; 37: 655-660
        • Smart Y.ch.
        • et al.
        Early pregnancy factor as a monitor for fertilization in women wearing intrauterine devices.
        Fertil Steril. 1982; 37: 201-204
        • Thomson A.W.
        • et al.
        Rosette inhibition levels during early human gestation.
        J. Rep Imm. 1980; 2: 263-268
        • Cooper D.W.
        • Aitken R.J.
        Failure to detect altered rosette inhibition titres in human pregnancy serum.
        J. Rep and Fert. 1981; 61: 241-245
        • Kosasa T.
        • et al.
        Early detection of implantation using a radioimmunoassay specific for human chorionic gonadotropin.
        J. Clin End and Metab. 1973; 36: 622-624
        • Bloch S.K.
        Occult pregnancy. A pilot study.
        Obstet and Gynecol. 1976; 48: 365-368
        • Miller J.F.
        • et al.
        Fetal loss after implantation. A prospective study.
        Lancet. 1980; ii: 554-556
        • Edmonds D.K.
        • et al.
        Early embryonic mortality in women.
        Fertil Steril. 1982; 38: 447-453
        • Whittaker P.G.
        • et al.
        Unsuspected pregnancy loss in healthy women.
        Lancet. 1983; i: 1126-1127
        • Wilcox A.J.
        Measuring early pregnancy loss: laboratory and field methods.
        Fertil Steril. 1985; 44: 366-374
        • Beling C.G.
        • et al.
        Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception.
        Am J. Obst and Gyn. 1976; 125: 855-858
        • Landesman R.
        • et al.
        Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
        Fertil Steril. 1976; 27: 1062-1066
        • Sharpe R.M.
        • et al.
        Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
        J. Clin End and Metab. 1977; 45: 496-499
        • Nilsson C.G.
        • Lahteenmaki P.
        Fertilization in women with intrauterine devices.
        Lancet. 1977; ii: 1126
        • Klein T.A.
        • Mishell D.R.
        Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
        Am J. Obst and Gyn. 1977; 129: 626-628
        • Aubert J.M.
        • et al.
        Assessment of human chorionic gonadotropin (hCG) levels during luteal phase in women using intrauterine contraception.
        Contraception. 1977; 16: 557-562
        • Hodgen G.D.
        • et al.
        Transitory hCG-like activity in the urine of some IUD users.
        J Clin End and Metab. 1970; 46: 698-701
        • Saxena B.B.
        • Landesman K.
        Does implantation occur in the presence of an IUD?.
        Research in Reproduction. 1978; 10: 1-2
        • Seppala M.
        • et al.
        Pregnancy-specific B1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
        J. Clin End and Metab. 1978; 47: 1216-1219
        • Keller P.J.
        • Soyka E.
        Abortifacient effect of intrauterine contraceptive devices?.
        Gynecol and Obstet Invest. 1978; 9: 219-221
        • Kort H.
        • Van Der Walt L.A.
        The intra-uterine contraceptive device — contraceptive or abortifacient?.
        South Africa Med J. 1978; 53: 864-866
        • Nilsson C.G.
        • et al.
        Detection of beta-subunit hCG in plasma of IUD users as an indication of frequency of conception.
        Int J. Fert. 1979; 24: 134-137
        • Dattatreyamurty B.
        • et al.
        Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
        Contraception. 1979; 19: 213-221
        • Orloff V.S.
        • et al.
        Human chorionic gonadotropin B-subunit-like immunoreactive material in the plasma of women wearing an intrauterine progesterone contraceptive system.
        Am J. Obst and Gyn. 1979; 134: 632-637
        • Shalit A.
        • et al.
        Human chorionic gonadotropin in intrauterine device users.
        Int J. Fert. 1980; 25: 134-136
        • Ylikorkala O.
        • et al.
        Trophoblastic markers in women using intrauterine contraception.
        Obst and Gyn. 1980; 55: 329-331
        • Custo G.M.
        • Carenza L.
        Levels of hCG in subjects using the Progestasert intrauterine progesterone systems.
        Contraception. 1980; 21: 311-317
        • Huang S.-C.
        The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
        J. Clin End and Metab. 1984; 58: 646-653
        • Segal S.J.
        • et al.
        Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
        Fertil Steril. 1985; 44: 214-218
        • Tamsen L.
        • Eneroth P.
        Serum levels of pregnancy-specific B1-Glycoprotein (SPI) and human chorionic gonadotropin (B-hCG) in women using an intrauterine device.
        Contraception. 1986; 33: 497-501
      1. Wilcox, A.J. Math Eq Urinary hCG among intrauterine device users: Detection with a highly specific and sensitive assay (submitted for publication).

        • Armstrong E.G.
        • et al.
        Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, nonpregnant and pregnant individuals.
        J. Clin End and Metab. 1984; 59: 867-874
        • Fisnel S.B.
        • et al.
        Human chorionic gonadotropin secreted by pre-implantation embryos cultured Math Eq.
        Science. 1984; 223: 816-818
        • Ahlgren M.
        Migration of spermatozoa to the Fallopian tubes and the abdominal cavity in women, including some immunological aspects.
        in: Diss. Lund. Studentlitteratur, Lund1969
        • Ahlgren M.
        • et al.
        Sperm transport and survival in women with special reference to the Fallopian tube.
        in: Thibault C. Hafez E.S.E. Transport, Survie et Pouvoir Fécondant des Spermatozoïdes chez les Vertébrés. INSERM, Paris1973
        • Malkani P.K.
        • Sujan S.
        Sperm migration in the female reproductive tract in the presence of intrauterine devices.
        Am J. Obst and Gyn. 1964; 88: 963-964
        • Morgenstern L.L.
        • et al.
        Observations on spermatozoa in the human uterus and oviducts in the chronic presence of intrauterine devices.
        Am J. Obst and Gyn. 1966; 96: 114-118
        • Moyer D.L.
        • et al.
        Sperm distriuution and degradation in the human female reproductive tract.
        Obst and Gyn. 1970; 35: 831-840
        • Sagiroglu N.
        Phagocytosis of spermatozoa in the uterine cavity of woman using intrauterine device.
        Int J. Fert. 1971; 16: 1-14
        • Croxatto H.B.
        • et al.
        Studies on sperm migration in the human female genital tract.
        in: Thibault C. Hafez E.S.E. Transport, Survie et Pouvoir Fécondant des Spermatozoïdes chez les Vertébrés. INSERM, Paris1973
        • Settlage D.S.
        • et al.
        Sperm transport from the external cervical os to the Fallopian tubes in women: a time and quantitation study.
        Fertil Steril. 1973; 24: 655-661
        • Tredway D.R.
        • et al.
        Effect of intrauterine devices on sperm transport in the human being: Preliminary report.
        Am J. Obst and Gyn. 1975; 123: 734-735
        • El-Habashi M.
        • et al.
        Effect of Lippes loop on sperm recovery from human Fallopian tubes.
        Contraception. 1980; 22: 549-555
        • Koch U.J.
        Sperm migration in the human female genital tract with and without intrauterine devices.
        Acta Europea Fertilitatis. 1980; 2: 33-60
        • Aref I.
        • et al.
        Effect of copper IUD's on sperm transport in the human oviduct. Reproductive Health Care.
        in: International Symposium, October 10–151982 (Maui, Hawaii, USA)
        • Croxatto H.B.
        • et al.
        A simple nonsurgical technique to obtain unimplanted eggs from human uteri.
        Am J. Obst and Gyn. 1972; 112: 662-668
        • Croxatto H.B.
        • et al.
        Studies on the duration of egg transport in the human oviduct. I. The time interval between ovulation and egg recovery from the uterus in normal women.
        Fertil Steril. 1972; 23: 447-458
        • Díaz S.
        • et al.
        Studies on the duration of ovum transport by the human oviduct. III. Time interval between the luteinizlng hormone peak and recovery of ova by transcervical flushing of the uterus in normal women.
        Am J. Obst and Gyn. 1980; 137: 116-121
        • Croxatto H.B.
        • et al.
        Studies on the duration of egg transport by the human oviduct. II. Ovum location at various intervals following luteinizing hormone peak.
        Am J. Obst and Gyn. 1978; 132: 629-634
        • Croxatto H.B.
        The duration of egg transport and its regulation in mammals.
        in: Coutinho E.M. Fuchs F. Physiology and Genetics of Reproduction. Plenum Publishing Corporation, New York1974: 159-166 (Part B)
      2. Alvarez, F. Math Eq New insight on the mode of action of intrauterine contraceptive devices in women. New Engl J. Med (accepted for publication).

        • Croxatto H.B.
        • et al.
        Time interval between LH peak and ovulation in women.
        in: Ebling F.J.G. Henderson I.W. Biological and Clinical Aspects of Reproduction. Excerpta Medica, Amsterdam1976: 282-284
        • World Health Organization
        Task Force on Methods for the Determination of the Fertile Period. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17-Beta, luteinizing hormone, follicle-stimulating hormone and progesterone. I. Probit analysis.
        Am J. Obst and Gyn. 1980; 138: 383-390
        • Ortiz M.E.
        • et al.
        Postovulatory aging of human ova. I. Light microscopic observations.
        Gamete Research. 1982; 6: 11-17
        • Hurst P.R.
        • et al.
        Leucocytes are consistently associated with degenerating embryos in IUD-bearing rhesus monkeys.
        Nature. 1977; 266: 331-333
        • Hurst P.R.
        • et al.
        A study of uterine embryos recovered from rhesus monkeys fitted with intrauterine devices.
        Fertil Steril. 1980; 33: 69-76
        • Larsson B.
        • et al.
        The influence of copper on the Math Eq motility of the human Fallopian tube.
        Am J. Obst Gyn. 1976; 125: 682-690
        • Larsson B.
        • Hamberger L.
        Tne concentration of copper in human uterine secretion during four years after insertion of a copper-containing intrauterine device.
        Fertil Steril. 1977; 28: 624-626
        • Zamboni L.
        • et al.
        Fine structure of the human ovum in the pronuclear stage.
        J Cell Biol. 1966; 30: 579-600
        • Quijada S.
        • et al.
        Fertility inhibition by intraoviductal copper beads in rabbits.
        Contraception. 1978; 17: 553-562